Hoeben E - Search Results

1

Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures.

Rodrigues RM, Kollipara L, Chaudhari U, Sachinidis A, Zahedi RP, Sickmann A, Kopp-Schneider A, Jiang X, Keun H, Hengstler J, Oorts M, Annaert P, Hoeben E, Gijbels E, De Kock J, Vanhaecke T, Rogiers V, Vinken M. Rodrigues RM, et al. Among authors: hoeben e. Arch Toxicol. 2018 Jun;92(6):1939-1952. doi: 10.1007/s00204-018-2214-z. Epub 2018 May 14. Arch Toxicol. 2018. PMID: 29761207 Free PMC article.

2

LC-MS/MS Analysis of Bile Acids in In Vitro Samples.

Dewaele D, Annaert P, Hoeben E. Dewaele D, et al. Among authors: hoeben e. Methods Mol Biol. 2019;1981:15-23. doi: 10.1007/978-1-4939-9420-5_2. Methods Mol Biol. 2019. PMID: 31016645

3

Identification of novel inhibitors of rat Mrp3.

De Vocht T, Buyck C, Deferm N, Qi B, Van Brantegem P, van Vlijmen H, Snoeys J, Hoeben E, Vermeulen A, Annaert P. De Vocht T, et al. Among authors: hoeben e. Eur J Pharm Sci. 2021 Jul 1;162:105813. doi: 10.1016/j.ejps.2021.105813. Epub 2021 Mar 19. Eur J Pharm Sci. 2021. PMID: 33753214

4

Population pharmacokinetics of JNJ-37822681, a selective fast-dissociating dopamine D₂-receptor antagonist, in healthy subjects and subjects with schizophrenia and dose selection based on simulated D₂-receptor occupancy.

Hoeben E, Neyens M, Mannaert E, Schmidt M, Vermeulen A. Hoeben E, et al. Clin Pharmacokinet. 2013 Nov;52(11):1005-15. doi: 10.1007/s40262-013-0084-3. Clin Pharmacokinet. 2013. PMID: 23754735 Clinical Trial.

5

Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus.

Hoeben E, De Winter W, Neyens M, Devineni D, Vermeulen A, Dunne A. Hoeben E, et al. Clin Pharmacokinet. 2016 Feb;55(2):209-23. doi: 10.1007/s40262-015-0307-x. Clin Pharmacokinet. 2016. PMID: 26293616 Clinical Trial.

6

Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies.

Salih H, Anghelescu I, Kezic I, Sinha V, Hoeben E, Van Nueten L, De Smedt H, De Boer P. Salih H, et al. Among authors: hoeben e. J Psychopharmacol. 2015 Apr;29(4):414-25. doi: 10.1177/0269881115573403. Epub 2015 Mar 3. J Psychopharmacol. 2015. PMID: 25735992 Clinical Trial.

7

Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects.

Hoeben E, Smit JW, Upmalis D, Rusch S, Schaffler K, Reitmeir P, Mangold B. Hoeben E, et al. Pain. 2012 Aug;153(8):1648-1656. doi: 10.1016/j.pain.2012.04.018. Epub 2012 Jun 15. Pain. 2012. PMID: 22703892

8

Identification of IL-6 as one of the important cytokines responsible for the ability of mononuclear cells to stimulate Sertoli cell functions.

Hoeben E, Wuyts A, Proost P, Van Damme J, Verhoeven G. Hoeben E, et al. Mol Cell Endocrinol. 1997 Sep 19;132(1-2):149-60. doi: 10.1016/s0303-7207(97)00132-9. Mol Cell Endocrinol. 1997. PMID: 9324056

9

Characterization of newly established testicular peritubular and prostatic stromal cell lines: potential use in the study of mesenchymal-epithelial interactions.

Hoeben E, Briers T, Vanderstichele H, De Smet W, Heyns W, Deboel L, Vanderhoydonck F, Verhoeven G. Hoeben E, et al. Endocrinology. 1995 Jul;136(7):2862-73. doi: 10.1210/endo.136.7.7789311. Endocrinology. 1995. PMID: 7789311

10

Cytokines derived from activated human mononuclear cells markedly stimulate transferrin secretion by cultured Sertoli cells.

Hoeben E, Van Damme J, Put W, Swinnen JV, Verhoeven G. Hoeben E, et al. Endocrinology. 1996 Feb;137(2):514-21. doi: 10.1210/endo.137.2.8593797. Endocrinology. 1996. PMID: 8593797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page